The Oncotype DX Test: For the Best-Informed Treatment Decision

The Oncotype DX breast cancer test is intended to be used for women recently diagnosed with either early-stage invasive breast cancer or DCIS (non-invasive) breast cancer. This unique genomic test looks at the activity of certain genes in your breast tumor tissue to provide personalized information that can help you and your doctor tailor treatment to your individual cancer. This pioneering genomic test was developed to eliminate the “one-size-fits-all” approach to cancer treatment that often leads to the over-treatment or under-treatment of early-stage breast cancer.

If you have early-stage invasive breast cancer, the Oncotype DX test can tell you the likelihood that you may benefit from chemotherapy, as well as the chances of your breast cancer returning.  If you have DCIS, the Oncotype DX test can help to predict whether your cancer may come back in the same breast. Based on its ability to provide critical information for treatment decision making, the Oncotype DX test is recognized worldwide as a new standard of care for women with early-stage breast cancer.

What is Genomic Testing?

The Oncotype DX breast cancer test is based on genomic science. Unlike genetics, which can help to tell you your risk for getting cancer, genomics can help you once you have cancer to choose your course of care. Learn More »

Oncotype DX for Breast Cancer

The Oncotype DX breast cancer test gives you additional information based on the unique biology of your individual tumor. This information can help you and your doctor make decisions about your care and increase confidence that your treatment is tailored for you. Learn More »

Oncotype DX Scores

Your Oncotype DX test results include your Recurrence Score or DCIS Score result. Your score can help you and your doctor choose what kind of treatment, if any, you should have after your surgery. Learn More »

Insurance Coverage

Most insurance carriers cover the Oncotype DX breast cancer test. In addition, Genomic Health offers a program to help you secure access to the test.
Learn More »


Get answers to common questions about the Oncotype DX test. Learn More »